Medical devices

This Overview guides you to core materials on medical devices within the Life Sciences practice area, explaining the regulatory framework, key processes and issues practitioners must navigate.

In Great Britain, the principal regime is the UK Medical Devices Regulations 2002 (as amended) administered by the MHRA, with UKCA/CE marking recognised under transitional arrangements. Northern Ireland applies EU rules under the Windsor Framework. Practitioners should understand device classification, conformity assessment via Approved Bodies or self‑declaration, clinical investigations, applicable labelling and information requirements, and the roles of manufacturers, authorised representatives, importers and distributors.

Post‑market obligations are central: vigilance and reporting of serious incidents and field safety corrective actions, post‑market surveillance planning, device identification and traceability, and recall coordination. Borderline determinations (for example, devices–medicines, cosmetics or IVDs), software as a medical device and AI‑enabled functionality merit assessment; the MHRA’s Software and AI as a Medical Device Change Programme and guidance remain important references. Advertising and claims substantiation engage the UK MDR, consumer protection law and the CAP Code.

The Overview also highlights EU MDR/IVDR requirements relevant to cross‑border supply and Northern Ireland, product liability considerations, data protection for devices, procurement and market...

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

Powered by Lexis+®
Latest Life Sciences News
View Life Sciences by content type :

Popular documents